The pBRAF V600ETM test screens for the presence of BRAF V600E mutation in blood specimens using droplet digital PCR technology. The test targets lung, thyroid, colorectal and melanoma and it is useful for assessing whether the indicated therapies would be useful. It is suggested that if the test results are positive, dabrafenib and trametinib can be used as targeted therapy.
Patients who are treatment-naive.
Sample types: Blood
Turnaround time: 2-3 working days upon sample arrival
Why use BRAF V600ETM?
2-3 working days